Federal Health Minister Syed Mustafa Kamal announced on Monday that Pakistan aims to raise its pharmaceutical and medical device exports to $30 billion over the next five years through a new fast-track licensing system, 24NewsHD TV reported.
Chairing a review meeting of the Drug Regulatory Authority of Pakistan (DRAP), the minister emphasized that the government is fully committed to expanding the country’s presence in global healthcare markets. The session was attended by the Federal Secretary for Health, the CEO of DRAP, and other senior officials.
Kamal noted that Pakistan’s current exports of pharmaceuticals and medical devices remain below $1 billion, but with the collaboration of the Medical Devices Association, the sector is expected to undergo a major transformation. “This is not just a numerical goal—it represents Pakistan’s economic resilience and our determination to strengthen the national economy,” he said.
He further explained that the Ministry of Health and DRAP are closely reviewing the project’s progress to ensure the timely implementation of all necessary measures for entry into major global trading blocs.
The minister reaffirmed that regular follow-up meetings will be held to track performance and maintain consistency in the project’s execution, adding that the initiative aims to turn Pakistan’s pharmaceutical industry into a competitive export-driven sector.
About the Author
Written by the expert legal team at Javid Law Associates. Our team specializes in corporate law, tax compliance, and business registration services across Pakistan.
Verified Professional
25+ Years Experience